RECOMMENDATIONS FOR COVID-19 PREVENTION AND TESTING FOR HEMATOPOIETIC CELL TRANSPLANT CENTERS IN BRAZIL

September 2023

Authors

  • Ana Verena de Almeida Mendes Hospital São Rafael, Universidade Baiana, Brazil
  • Fabianne Carlesse Universidade Federal de São Paulo - UNIFESP/EPM, Brazil
  • Jessica Ramos Hospital Sírio Libanês
  • Márcia Garnica Maiolin Universidade Federal do Rio de Janeiro, Complexo Hospitalar de Niterói, Brazil
  • Clarisse Martins Machado Laboratório de Virologia, Instituto de Medicina Tropical da faculdade de Medicina da USP, Brazil

DOI:

https://doi.org/10.46765/2675-374X.2023v4n3p206

Abstract

From February 2020 to May 2023, 37,625,916 cases of COVID-19 were recorded in Brazil, which led to 2,173,359 hospitalizations due to severe acute respiratory syndrome (SARS) with 703,291 deaths due to COVID-19. More than 14 million cases were registered in 2021 and 2022. However, there was a significant drop in the number of hospitalizations for SARS and the COVID-19 fatality rate in 2022, which certainly reflects the impact of mass vaccination in the country, started in February 2021.

Downloads

Published

10/17/2023

How to Cite

Mendes, A. V. de A. ., Carlesse, F. ., Ramos, J., Garnica Maiolin, M. ., & Machado, C. M. (2023). RECOMMENDATIONS FOR COVID-19 PREVENTION AND TESTING FOR HEMATOPOIETIC CELL TRANSPLANT CENTERS IN BRAZIL : September 2023. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 4(3), 206. https://doi.org/10.46765/2675-374X.2023v4n3p206

Issue

Vol. 4 No. 3 (2023): Journal of Bone Marrow Transplantation and Cellular Therapy

Section

Original article

License

Copyright (c) 2023 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.